It was reported that on (b)(6) 2023, a mitraclip procedure was performed to treat functional mitral regurgitation (mr) with a grade of 4+, enlarged atrium, and relatively small mitral valve orifice.A mitraclip xtr was implanted without issues, reducing he mr to a grade of 2-3.On december 1, 2023, the patient presented with symptoms of chest tightness.On january 7, 2024, an echocardiogram was performed and revealed recurrent mitral regurgitation (mr) with a grade of 4+ and that the previously implanted mitraclip had detached from the posterior leaflet and remained attached to the anterior leaflet (single leaflet device attachment/slda).On (b)(6) 2024, a mitral valve replacement was performed.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific issue.Based on available information, the cause of the reported agnia cannot be determined.The cause of the reported incomplete coaptation is due to the patient anatomy (thickened leaflets).The reported mitral regurgitation (mr) appears to be a cascading effect of the reported incomplete coaptation.Additionally, the reported patient effect of mitral regurgitation and agnia are listed in the instructions for use, and are known possible complications associated with mitraclip procedures.The reported surgical intervention and hospitalization were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|